Epidemiologie und Prävention der koronaren Herzkrankheit

  • A. Weisswange

Zusammenfassung

In diesem Jahrhundert hat die koronare Herzkrankheit (KHK) weltweit zugenommen (Epstein 1971) und überall dort epidemische Ausmaße erlangt, wo Infektionskrankheiten und Mangelernährung als Todesursachen weitgehend beherrscht werden konnten. Hier ist sie zusammen mit den atherosklerotischen Erkrankungen an den zerebralen und peripheren Gefäßen zur Haupttodesursache der Erwachsenen geworden.

Die Erforschung dieser Krankheit beschäftigt längst nicht mehr nur Pathologen und Internisten, wie zu Beginn des Jahrhunderts, sondern auch so verschiedene wissenschaftliche Disziplinen wie Molekularbiologie, Epidemiologie und Verhaltensforschung. Die hierbei gewonnenen Erkenntnisse vermitteln sehr differenzierte Vorstellungen über Ursachen und Pathogenese, aber sie werfen bis jetzt noch mehr Fragen auf, als sie Antworten bringen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. AHA Position Statement (1986 a) Diagnoses and treatment of primary hyperlipidemia in childhood. Circulation 74 (Suppl A):1181Google Scholar
  2. AHA Position Statement (1986 b) Coronary risk factor modification in children: Exercise. Circulation 74 (Suppl A): 1189Google Scholar
  3. American Diabetes Association Committee on Food and Nutrition (1979) Principles of nutrition and dietary recommendations for individuals with diabetes mellitus. Diabetes 28:1027Google Scholar
  4. Anderson TW, Leriche WH (1971) Sudden death from ischemic heart disease in Ontario and in correlation with water hardness and other factors. Canad med Ass J 105:155PubMedGoogle Scholar
  5. Antiplatelet Trialists’ Collaboration (1988) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 296:320Google Scholar
  6. Assman G (1982) Lipidstoffwechsel und Atherosklerose. Schattauer, Stuttgart New YorkGoogle Scholar
  7. Assmann G et al. (1993) Aktuelle Hinweise zur Primär- und Sekundärprävention der koronaren Herzkrankheit. Dtsch Ärzteblatt 90:3058Google Scholar
  8. Becker CG, Dubin T (1977) Activation of factor XII by tobaccoglycoprotein. J exp Med 146:457PubMedGoogle Scholar
  9. Benowitz NL (1986) Clinical pharmacology of nicotine. Ann Rev Med 37:21PubMedGoogle Scholar
  10. Beral V (1977) Mortality among oral contraceptives users. Royal College of General Practitioners: Oral contraceptive study. Lancet II:727Google Scholar
  11. Berg A (1963) A new serum type in man — the Lp system. Acta pathol microbiol scand 59:369PubMedGoogle Scholar
  12. Bernstein DS, Sadowsky N, Hegstedt DM, Guri CD, Stare JF (1966) Prevalance of osteoporosis in high and low fluoride areas in North Dakota. J Amer med Ass 198:499Google Scholar
  13. Bierenbaum ML, Fleischmann A, Raichelson R, Hayton T, Watson PB (1973) Ten-year experience of modified-fat diets on younger men with coronary heart disease. Lancet I:1404Google Scholar
  14. Bierenbaum ML, Fleischmann A, Dunn J, Arnold J (1975) Possible toxic water factor in coronary heart disease. Lancet I:1008Google Scholar
  15. Blankenhorn DA, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L (1987) Benefical effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. J Amer med Ass 257:3233Google Scholar
  16. Blum CB, Levy RI (1987) Role of dietary intervention in the primary prevention of coronary heart disease. Cardiology 74:2PubMedGoogle Scholar
  17. Böttiger LE, Carlson LA (1980) Risk factors for ischemic vascular death for men in the Stockholm prospective study. Atherosclerosis 36:389Google Scholar
  18. British Cardiac Society Working Group on Coronary Prevention (1987) Conclusion and recommendations. Brit Heart J 57:188Google Scholar
  19. Brown MS, Goldstein JL (1984) How LDL-receptors influence cholesterol and atherosclerosis. Sci Amer 251:58PubMedGoogle Scholar
  20. Brunzell JD, Schrott HG, Motulski AG et al (1976) Myocardial infarction in the familial form of hypertriglyceridemias. Metabolism 25:313PubMedGoogle Scholar
  21. Burke GL, Cresanta JL, Shear CL, Miner MH, Berenson GS (1986) Cardiovascular risk factors and their modification in children. Cardiology Clinics 4:33PubMedGoogle Scholar
  22. Bush TL, Cowan L, Barrett-Conner E et al (1983) Estrogen use and cardiovascular mortality. The Lipid Research Clinics follow up study (Abstr). Amer J Epidemiol 118:450Google Scholar
  23. Castelli WP (1984) Epidemiology of coronary heart disease. Amer J Med 76 (Suppl 2a):4PubMedGoogle Scholar
  24. Castelli WP, Doyle JT, Gordon T et al (1977) HDL-cholesterol and other lipids in CHD. The cooperative lipoprotein phenotyping study. Circulation 55:767PubMedGoogle Scholar
  25. Castelli W, Leaf A (1985) Identification and assessment of cardiac risk — an overview. Cardiology Clinics 3:171Google Scholar
  26. Christianson JB, Krischan I, Nobrega FI, Davis CS, Smoldt RK, Harris AM (1981) The Mayo three-community hypertension central program. V. Cost-effectiveness of intervention. Mayo Clin Proc 56:11PubMedGoogle Scholar
  27. Chute CG, Baron J, Plymate SR, Kiel DP, Pavia AT, Lozner EG, O’Keefe T, MacDonald OJ (1987) Sex hormones and coronary artery disease. Amer J Med 83:853PubMedGoogle Scholar
  28. Committee of Principal Investigators (1980) Report on a WHO cooperative trial on primary prevention of ischemic heart disease using Clofibrate to lower serum cholesterol — mortality follow-up. Lancet II:379Google Scholar
  29. Committee of Principal Investigators (1984) WHO cooperative trial of primary prevention of ischemic heart disease with Clofibrate to lower serum cholesterol: Trial mortality followup. Lancet II:600Google Scholar
  30. Coronary Drug Project Research Group (1986) Fifteen year mortality in coronary drug project patients: Long-term benefits with niacin. J Amer Coll Cardiol 8:1245Google Scholar
  31. Constantini AN (1995) The fungal/mycotoxin etiology of atherosclerosis and hyperlipemia. Medi-Verlag Dr. B. Guzek, Hamburg (im Druck)Google Scholar
  32. Crawford MD, Gardner MJ, Morris JN (1971) Cardiovascular disease and the mineral contents of drinking water. Br med Bull 27:21PubMedGoogle Scholar
  33. Crawford MD, Clayton DG, Stanley F, Shaper AG (1977) An epidemiological of sudden death in hard and soft water areas. J chron Dis 30:69PubMedGoogle Scholar
  34. Cunningham MJ, Pasternak RC (1988) The potential role of viruses in the pathogenesis of atherosclerosis (Editorial). Circulation 77:964PubMedGoogle Scholar
  35. Cutler JA, Furberg CD (1985) Drug treatment trial in hypertension. A review. Prev Med 14:499PubMedGoogle Scholar
  36. Davia JE, Hallal FJ, Cheitlin MD et al (1974) Coronary artery disease in young patients: Arteriographic and clinical review of 40 cases aged 35 and under. Amer Heart J 87:689PubMedGoogle Scholar
  37. Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyashu U (1969) A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation 39/40 (Suppl II): 1Google Scholar
  38. DHP-Forschungsverbund (1993) Erfolgreiche Senkung kardiovaskulärer Risikofaktoren in der Deutschen Herz-Kreislauf-Präventionsstudie (DHP) zwischen 1984/5 und 1991/2. Z Gesundheitswiss 2:137Google Scholar
  39. Dolder MA, Oliver MF (1975) Myocardial infarction in young men. Study of risk factors in nine countries. Br Heart J 37:493PubMedGoogle Scholar
  40. Doll R, Peto R (1976) Mortality in relation to smoking: 20 years observation on male British doctors. Br med J 2:1525PubMedGoogle Scholar
  41. Dorr AE, Gundersen K, Schneider JC, Spencer TW, Martin WB (1978) Colestipol hydrochloride in hypercholesterolaemic patients — effect on serum cholesterol and mortality. J chron Dis 31:5PubMedGoogle Scholar
  42. Dörr W (1972) Pathologie der Koronargefäße. Anthropologische Aspekte. Sitzungsbericht Heidelberger Akad Wiss math naturwiss Klasse. Springer, Berlin Heidelberg New YorkGoogle Scholar
  43. Doyle JT, Dawber TR, Kannel WB, Heslin AS, Kahn HA (1962) Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. New Engl J Med 266:796Google Scholar
  44. Doyle JT, Dawber TR, Kannel WB, Kinch SH, Kahn HA (1964) The relationship of cigarette smoking to coronary heart disease. The second report of the combined experience of the Albany, N Y and Framingham, Mass Studies. J Amer med Ass 190:108Google Scholar
  45. Dube M, Green CR (1982) Methods of collection of smoke for analytical purposes. Rec Advanc Tobacco Sci 8:42Google Scholar
  46. EAS Study Group (1987) Strategies for the prevention of coronary heart disease: a policy statement for the European Atherosclerosis Society. Europ Heart J 8:77Google Scholar
  47. Elwood PC, Abernathy M, Morton M (1974) Mortality in adults and trace elements in water. Lancet II:1470Google Scholar
  48. Epstein FH (1971) International trends in coronary heart disease epidemiology. Ann clin Res 3:293PubMedGoogle Scholar
  49. Epstein FH (1983) Epidemiologie der koronaren Herzkrankheit. Intern Welt 6:57Google Scholar
  50. Feussner G, Feussner V, Ziegler R (1994) Lipoprotein (a) [LP(a)] — ein genetisch bedingter Risikofaktor für Arteriosklerose. Med Klinik 89:198Google Scholar
  51. Fleckenstein A, Janke J, Döring HJ, Leder O (1974) Myocardial fiber necrosis due to intracellular Ca-overload — a new principle cardiac pathophysiology. In: Dhalla NS (Hrsg) Myocardial biology 4: Recent advances in studies on cardiac structure and metabolism, S 563. University Park, BaltimoreGoogle Scholar
  52. Fredrickson DS, Levy RS (1965) System for phenotyping hyperlipoproteinemia. Circulation 31:321PubMedGoogle Scholar
  53. Fredrickson DS (1971) An international classification of hyperlipidemia an hyperlipoproteinemia. Ann intern Med 75:471PubMedGoogle Scholar
  54. Fredrickson DS (1975) It’s time to be practical (Editorial). Circulation 51:209PubMedGoogle Scholar
  55. Friedman GD, Dales LG, Ury HK (1979) Mortality in middleaged smokers and non-smokers. New Engl J Med 300:213PubMedGoogle Scholar
  56. Friedmann GD, Petitt DB, Bawol RD, Sieglaub AB (1981) Mortality in cigarette smokers and quitters. Effect of baseline differences. New Engl J Med 304:1407Google Scholar
  57. Fuster V, Chesebro JH, Brye RI et al (1981) Platelet survival and the development of coronary artery disease in the young adult: Effects of cigarette smoking, strong family history and medical therapy. Circulation 63:546PubMedGoogle Scholar
  58. Fuster V, Cohen M, Halperin J (1989) Aspirin in the prevention of coronary disease. N Engl J Med 321:183PubMedGoogle Scholar
  59. Fuster V, Badimon L, Badimon J, Chesebro J (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242, 310PubMedGoogle Scholar
  60. Gerrity RC (1981) The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. II. Migration of foam cells from atherosclerotic lesions. Amer J Pathol 103:181Google Scholar
  61. Gillis CR, Hole DJ, Hawthorne VM, Boyle P (1984) The effect of environmental tobacco smoke in two urban communities in the west of Scotland. Europ J resp Dis 65 (Suppl 133): 121Google Scholar
  62. Gohlke H (1983) Der transmurale Herzinfarkt vor dem 40. Lebensjahr. Habilitationsschrift, Albert-Ludwigs-Universität Freiburg i. Br.Google Scholar
  63. Goldstein JL (1973) Hyperlipidemia in coronary heart disease. I: Lipid levels in 500 survivors of myocardial infarction. J clin Invest 52:1533PubMedGoogle Scholar
  64. Goldstein JL, Schrott HG, Hazzard WB (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J clin Invest 52:1544PubMedGoogle Scholar
  65. Gordon T, Sorlie P, Kannel WB (1971) Coronary heart disease, atherosclerotic brain infraction, intermittent claudication — a multivariate analysis of some factors related to their incidence: Framingham Study, 16 year follow-up, Section 27. US Government Print OfficeGoogle Scholar
  66. Gotto AM (1995) Lipid lowering, regression and coronary events. Circulation 92:646PubMedGoogle Scholar
  67. Grosse-Ruyken FJ (1987) Das landesweite Präventionsprogramm der Ärztekammer Baden-Württemberg. Ärztebl Bd-Wttbg 42:324Google Scholar
  68. Grosse-Ruyken FJ, Nüssel E (1986) 7 gegen 7. Landesweites Programm mit 7 Aktionen gegen 7 Krankheiten. Was ist gemeint? Chronomed, EmsdettenGoogle Scholar
  69. Hammond EC, Horn D (1958) Smoking and death rates — report on fourty four months of follow-up of 187703 men. II: Death rates by cause. J Amer med Ass 166:1294Google Scholar
  70. Hjerman I, Holme I, Byre KV, Leren P (1981) Effect of diet and smoking intervention on the incidence of coronary heart disease, report from the Oslo Study Group of a randomized trial in health men. Lancet II:1303Google Scholar
  71. Hoffmeister H, Junge B, Schön D (1984) Prävention von Herz-Kreislauf-Krankheiten: Bewertung des Erfolges von Interventionsstudien — Ausgangssituation der Deutschen Herz-Kreilauf-Präventionsstudie (DHP). Bundesgesundheitsblatt 27:141Google Scholar
  72. Hopkins PN, Williams RR (1981) A survey of 246 suggested coronary risk factors. Atherosclerosis 40:1PubMedGoogle Scholar
  73. IPPPSH Collaborative Group (1985) Cardiovascular risk and risk factors in a randomized trial of treatment based in the betablocker Oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertension 3:379Google Scholar
  74. Johnson A (1977) Sex differentials in coronary heart disease. The explanatory role of primary risk factors. J Healt Soc Behav 18:46Google Scholar
  75. Kannel WB (1981) Update on the role of cigarette smoking in coronary artery disease. Amer Heart J 101:319PubMedGoogle Scholar
  76. Kannel W, Neaton J, Wentworth D et al (1986) Overall and coronary heart disease mortality rates in relation to major risk factors in 325 348 men screened for the MRFIT. Amer Heart J 112:825PubMedGoogle Scholar
  77. Kaplan N (1987) Antihypertensive drugs: How different classes can impact patients’ coronary heart disease risk profile and quality of life. Amer J Med 82 (Suppl IA):9PubMedGoogle Scholar
  78. Karppanen H, Pennanen R, Passinen L (1978) Minerals, coronary heart disease and sudden coronary death. Advanc Cardiol 25:9Google Scholar
  79. Kaufmann RL, Asal JPH, Soeldner JS, Wilmshorst EG, Lemaire JR, Gleason RE, White P (1975) Plasma lipid levels in diabetic children. Effect of diet restricted in cholesterol and saturated fats. Diabetes 24:672PubMedGoogle Scholar
  80. Kaufmann DW, Palmer JR, Rosenberg L, Shapiro S (1987) Cigar and pipe smoking and myocardial infarction in young men. Brit med J 294:1305Google Scholar
  81. Keys A (Hrsg) (1970) Coronary heart disease in seven countries. Circulation 41 (Suppl I):1Google Scholar
  82. Keys A (Hrsg) (1980) Smoking habits in sveen countries. A multivariate analysis of death and coronary heart disease. Vol 9, S 136–160. Harward University Press, CambridgeGoogle Scholar
  83. Khaw KT, Barrett-Connor E (1986) Family history of heart attack: a modifiable risk factor? Circulation 74:239PubMedGoogle Scholar
  84. Klag MJ, Ford DE, Mead LA et al. (1993) Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328:313PubMedGoogle Scholar
  85. Klimov AN, Zzbhitsky Y, Nagornev WA (1979) Immunochemical aspects of atherosclerosis. In: Paoletti R, Gotto AM Jr (Hrsg) Atherosclerosis Review, Bd 4, S 119. Raven, New YorkGoogle Scholar
  86. Knoke JD, Hunninghake DB, Heiss G (1987) Physiologic markers of smoking and their relation to coronary heart disease. The Lipid Clinics Coronary Primary Prevention Trial. Arteriosclerosis 7:478Google Scholar
  87. Koenig W, Resch KL, Hombach V, Ernst E (1994) Fibrinogen und kardiovaskuläres Risiko. Dtsch Ärzteblatt 91:A2410Google Scholar
  88. Kottke TE, Puska P, Salonen JT et al (1985) Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Amer J Epidemiol 121:697Google Scholar
  89. Kovacsics H, Roskamm H, Stürzenhofecker P, Petersen J (1977) Risikofaktoren und Koronarmorphologie bei 218 männlichen Infarktpatienten unter 40 Jahren. Z Kardiol 66:685PubMedGoogle Scholar
  90. Law MR, Wald NJ, Wu T, et al. (1994a) Systematic underestimation of association between serum cholesterol concentration and ischemic heart disease in observational studies: data from the BUPA study. Brit Med J 308:363PubMedGoogle Scholar
  91. Law MR, Wald NJ, Thompson SG (1994 b) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease. Brit Med J 308:367PubMedGoogle Scholar
  92. Law MR, Wald NJ, Thompson SG (1994 c) Assessing possible hazards of reducing serum cholesterol. Brit Med J 308:373PubMedGoogle Scholar
  93. Learner DJ, Kannel WB (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year followup of the Framingham population. Amer Heart J 111:383Google Scholar
  94. Lee PN, Chamberlain J et al (1988) Relationship of passive smoking to risk of lung cancer and other smoking-associated disease. Br J Cancer 54:97Google Scholar
  95. Leren P (1970) The Oslo Diet Heart Study. 11 year report. Circulation 42:935PubMedGoogle Scholar
  96. Levine PH (1973) An acute effect of cigarette smoking on platelet function: A possible link between smoking and arterial thrombosis. Circulation 48:619PubMedGoogle Scholar
  97. Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. II: The relationship of reduction in incidence of coronary heart disease to cholesteral lowering. J Amer med Ass 251:351Google Scholar
  98. Luoma H, Helminen SKJ, Ranta H, Rytömaa J, Meurman JH (1973) Relationships between the fluoride and magnesium concentrations in drinking water and some components in serum related to cardiovascular disease in man from four rural districts in Finland. Scand J Clin lab Invest 32:217PubMedGoogle Scholar
  99. Manson JE, Tosteson H, Ridker PM et al (1992) The primary prevention of myocardial infarction. N Engl J Med 326:1406PubMedGoogle Scholar
  100. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D (1986) Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361662 men. Lancet II:933Google Scholar
  101. Masironi R (1969) Trace elements and cardiovascular disease. Bull Wld Hlth Org 40:305Google Scholar
  102. Mattila KJ (1993) Dental infections as a risk factor for acute myocardial infarction. Eur Heart J 14(Suppl):51PubMedGoogle Scholar
  103. McGee D, Gordon T (1976) Results of the Framingham study applied to four other US-based epidemiologic studies of cardiovascular disease. Washington/DC: Publ No (NIH) 76–1083, US Dept HEWGoogle Scholar
  104. McGill HC Jr, Eggen DA, Strong JP (1965) Atherosclerotic lesions in the aorta and coronary arteries of man. In: Roberts JR Jr, Straus R (Hrsg) Comparative atherosclerosis, S 311–326. Harper&Row, New YorkGoogle Scholar
  105. McGill HC Jr, Arias-Stella J, Carbonelli LM, Correa P, DeVeyra EA Jr, Donoso S, Eggen DA et al (1968) General findings of the International Atherosclerosis Project. Lab Invest 18:498Google Scholar
  106. McMillan GC (1978) Atherogenesis: The process from normal to lesion. In: Chandler AB, McMillan GC, Nelson CB, Schwartz CJ, Wessler S (Hrsg) The thrombotic process in atherogenesis, S 3–10. Plenum Press, New YorkGoogle Scholar
  107. McMurray J, Slattery J (1984) Scandinavian Simvastatin Study. Letter to the editor. Lancet 344:1765Google Scholar
  108. Miller GJ (1978) High density lipoprotein, low density lipoprotein and coronary heart disease (Editorial). Thorax 33:137PubMedGoogle Scholar
  109. Morris JN, Crawford MD, Heady JA (1961) Hardness of local water supplies and mortality from cardiovascular disease in the country burroughs of England and Wales. Lancet I:860Google Scholar
  110. Morrison LM (1955) A nutritional program for prolongation of life in coronary atherosclerosis. J Amer med Ass 159:1425Google Scholar
  111. Multiple Risk Factor Intervention Trial Group (1977) Statistical lesign considerations in the NHLBI MRFIT. J chron Dis 30:261Google Scholar
  112. MRFIT Research Group (1982) Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. J Amer med Ass 248:1465Google Scholar
  113. MRC Research Committee (1965) Low-fat diet in myocardial infarction — a controlled trial. Lancet II:500Google Scholar
  114. MRC Research Committee (1968) Controlled trial of soy-bean oil in myocardial infarction. Lancet II:693Google Scholar
  115. MRC Working Party (1985) MRC trial in mild hypertension: principal results. Br med J 291:97Google Scholar
  116. Neufeld HN, Goldbourt U (1983) Coronary heart disease: Genetic aspects. Circulation 67:943PubMedGoogle Scholar
  117. Nüssel E, Buchholz L, Scheidt R (1984) Korrektur von Risikofaktoren in der Erst- und Zweitprophylaxe. In: Rosmann H (Hrsg) Koronarerkrankungen, Handbuch der Inneren Medizin, Bd IX/3, S 937–957. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  118. Physicians of the Newcastle upon Tyne Region (1971) Trial of Clofibrate in the treatment of ischemic heart disease. Br med J 4:767Google Scholar
  119. Porter JB, Hunter JR, Jick H et al (1985) Oral contraceptives and nonfatal vascular disease. Obstet Gynecol 66:1PubMedGoogle Scholar
  120. Research Committee of the Scottish Society of Physicians (1971) Ischemic heart disease: a secondary prevention trial using Clofibrate. Br med J 4:775Google Scholar
  121. Richard JC (1987) Les facteurs de risque coronarien. Le paradoxe français. Arch Mal Coeur 80 (suppl): 17PubMedGoogle Scholar
  122. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE (1995) The primary prevention of coronary heart disease in women. New Engl J Med 332:1758PubMedGoogle Scholar
  123. Rinzler SH (1968) Primary prevention of coronary heart disease by diet. Bull N Y Acad Med 4:936Google Scholar
  124. Rissanen AM, Nikkilä EE (1981) Role of family history in coronary heart disease at young age. In: Roskamm H (Hrsg) Myocardial infraction at young age, S 38. Springer, Berlin Heidelberg New YorkGoogle Scholar
  125. Robinson JC, Forbes WF (1975) The role of carbon monoxide in cigarette smoking. I: Carbon monoxide yield from cigarettes. Arch Environ Health 24:27Google Scholar
  126. Rose G, Thompson WB, Williams RT (1965) Corn oil in treatment of ischemic heart disease. Br med J 1:1531PubMedGoogle Scholar
  127. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S (1987) The risk of myocardial infarction after quitting smoking in men under 55 years of age. New Engl J Med 313:1511Google Scholar
  128. Rosenhammer G, Carlson LA (1980) Effect of combined clofibrate-nicotine acid treatment in ischemic heart disease. Atherosclerosis 37:129Google Scholar
  129. Ross R (1981) Atherosclerosis — a problem of the biology of arterial wall cells and their interaction with blood components. Arteriosclerosis 1:293PubMedGoogle Scholar
  130. Ross R (1986) The pathology of atherosclerosis — an update. New Engl J Med 314:488PubMedGoogle Scholar
  131. Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. New Engl J Med 295:369PubMedGoogle Scholar
  132. Scandinavian Simvastatin Study Group (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383Google Scholar
  133. Schroeder HA, Balassa JJ (1961) Abnormal trace metabolism in man: Cadmium. J chron Dis 14:236PubMedGoogle Scholar
  134. Schwartz JL (1987) Review and evaluations of smoking cessation methods: the United States and Canada 1978–1985. NIH Publ No 87–2940Google Scholar
  135. Schwartz JL, Rider G (1978) Review and evaluation of smoking control methods. The United States and Canada 1969–1977. HEW Publication No (CDC 79–8369Google Scholar
  136. Shamberger RJ, Tytko SA, Willis CE (1975) Selenium and heart disease. In: Hemphill H (Hrsg) Trace substances in environment health, Bd 9, S 15. University of Missouri, ColumbiaGoogle Scholar
  137. Simons LA (1986) Interrelations of lipids and lipoproteins with coronary artery disease in 19 countries. Amer J Cardiol 57 (Suppl G):5–10Google Scholar
  138. Smith JR, Landaw AS (1978) Smoker’s polycythemia. New Engl J Med 298:6PubMedGoogle Scholar
  139. Stamler J, Wentworth D, Neaton J (1986) Is the relationship between serum cholesterol and risk of death from coronary heart disease continuous and graded? Findings on the 356222 primary screenes of the Multiple Risk Factor Intervention Trial (MRFIT). J Amer med Ass 256:2823Google Scholar
  140. Stampfer MJ, Willet WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH (1985) A prospective study of postmenopausal estrogen therapy and coronary heart disease. New Engl J Med 313:1044PubMedGoogle Scholar
  141. Stary HC, Blankenhorn DH, Chandler AB et al (1992) A definition of the intima of human arteries and of its atherosclerosis-pone regions. Circulation 85:391PubMedGoogle Scholar
  142. Stary HC, Chandler AB, Dinsmore RE et al (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation 92:1355PubMedGoogle Scholar
  143. Stary HC, Chandler AB, Glagov S et al (1995) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Arterioscler Thromb 14:840Google Scholar
  144. Steering Committee of the Physician’s Health Study Group (1989) Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 321:129Google Scholar
  145. Study Group of the European Atheroslerosis Society: Strategy for the prevention of coronary heart disease. A policy statement for the European Atherosclerosis Society. Europ Heart J 8:77Google Scholar
  146. Sullivan JM, van der Zwaag R, Lemp GF, Hughe JP, Maddock V, Kroet FW, Ramanathan KB, Mirvis DM (1988) Postmenopausal estrogen use and coronary atherosclerosis. Ann intern Med 108:358PubMedGoogle Scholar
  147. Taylor WC, Pass TM, Shepard DS, Komaroff AL (1987) Cholesterol reduction and life expectancy. A model incorporating multiple risk factors. Ann intern Med 106:605PubMedGoogle Scholar
  148. Turpeinen O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuom R, Paavilainen E (1979) Dietary prevention of coronary heart disease — the Finnish Hospital Study. Int J Epidemiol 8:99PubMedGoogle Scholar
  149. US Dept of Health and Human Services (1986) The health consequences of involuntary smoking. A report of the Surgeon General. DHHS Publ No (CDC) 87–8398Google Scholar
  150. US Dept of Health and Human Services (1986) Smoking and health: A national status report. MMWR 73:1Google Scholar
  151. Waldron J (1986) Who do women live longer than men? J human Stress 2:2Google Scholar
  152. Walker AM, Jick H, Hunter JR, McEvoy J (1983) Vasectomy and nonfatal myocardial infarction: Continued observation indicates no elevation of risk. J Urol 130:936PubMedGoogle Scholar
  153. WHO European Collaborative Group (1983) Multifactorial trial in the prevention of coronary heart disease. III. Incidence and mortality results. Europ Heart J 4:141Google Scholar
  154. WHO European Collaborative Group (1986) European collaborative trial of multifactorial prevention of coronary heart disease. Lancet I.869Google Scholar
  155. WHO Expert Committee (1982) Prevention of coronary heart disease: report of a WHO expert committee. WHO Technical Report Series No 678Google Scholar
  156. Wilhelmsen L, Svardsudo K, Karsan-Bengtsen K et al (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. New Engl J Med 311:501PubMedGoogle Scholar
  157. Wilhelmsen L, Berglund G, Elmstedt D et al (1986) The multi-factor primary prevention in Göteborg, Sweden. Europ Heart J 7:279Google Scholar
  158. Willet WC, Green A, Stampfer MJ et al (1987) Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. New Engl J Med 317:1303Google Scholar
  159. Wingard DL (1982) The sex differential in mortality rates. Demographic and behavioral factors. Amer J Epidemiol 115:205Google Scholar
  160. Woodhill JM, Palmer AJ, Leelartgaerin B et al (1978) Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advanc exp Med Biol 109:317Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • A. Weisswange

There are no affiliations available

Personalised recommendations